Detection of Anti‐<scp>HLA</scp> Antibodies in Maternal Blood in the Second Trimester to Identify Patients at Risk of Antibody‐Mediated Maternal Anti‐Fetal Rejection and Spontaneous Preterm Delivery
Distribution of the number of citations over years.